Ruby C.Y. Lin

6.6k citations

80 papers · 4.9k · 2 hit papers · h-index 37

Impact in

Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Biochemistry top 1%
- Lipid metabolism and biosynthesis

Papers in

Molecular Biology 22
- Circular RNAs in diseases 7
Cancer Research 14
- MicroRNA in disease regulation 14

Co-authors: Margaret J. Morris (3 shared papers)Julie A. Owens (2 shared papers)D. Ross Laybutt (2 shared papers)Romain Barrès (1 shared paper)Julie R. McMullen (13 shared papers)Bianca C. Bernardo (11 shared papers)Brian J. Morris (8 shared papers)Ian W. Dawes (7 shared papers)
Journals: The FASEB Journal (4 papers)Journal of Thoracic Oncology (4 papers)Hypertension (3 papers)Critical Care Medicine (3 papers)International Journal of Obesity (2 papers)
Partner nations: Australia United States Switzerland

In The Last Decade

Ruby C.Y. Lin

78 papers receiving 4.8k citations

Ruby C.Y. Lin's Hit Papers

align trajectories log scale

Safety of bacteriophage therapy in severe Staphylococcus aureus infection 2020 · 351 citations

Peers

Countries citing papers authored by Ruby C.Y. Lin

Since Specialization

Citations

This map shows the geographic impact of Ruby C.Y. Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruby C.Y. Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruby C.Y. Lin more than expected).

Fields of papers citing papers by Ruby C.Y. Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruby C.Y. Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruby C.Y. Lin. The network helps show where Ruby C.Y. Lin may publish in the future.

Co-authors

The 25 scholars most cited alongside Ruby C.Y. Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ruby C.Y. Lin Line = papers co-authored together Ruby C.Y. Lin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Chronic high-fat diet in fathers programs β-cell dysfunction in female rat offspring Nature ·Sheau‐Fang Ng, Ruby C.Y. Lin, D. Ross Laybutt, Romain Barrès, Julie A. Owens, Margaret J. Morris Hit paper breakdown →	2010	976
2	Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function Proceedings of the National Academy of Sciences ·Bianca C. Bernardo, Xiao-Ming Gao, Catherine E. Winbanks, Esther J. H. Boey, Yow Keat Tham, Helen Kiriazis, Paul Gregorevic, Susanna Obad, Sakari Kauppinen, Xiao‐Jun Du, Ruby C.Y. Lin, Julie R. McMullen	2012	364
3	Safety of bacteriophage therapy in severe Staphylococcus aureus infection Nature Microbiology ·Aleksandra Petrović Fabijan, Ruby C.Y. Lin, Josephine Ho, Susan Maddocks, Nouri L. Ben Zakour, Jonathan R. Iredell, (unknown), Ali Khalid, Carola Venturini, Richard Chard, Sandra Morales, Indy Sandaradura, Tim Gilbey Hit paper breakdown →	2020	351
4	A Role for Phosphatidic Acid in the Formation of “Supersized” Lipid Droplets PLoS Genetics ·Weihua Fei, Guanghou Shui, Yuxi Zhang, Natalie Krahmer, Charles Ferguson, Tamar S. Kapterian, Ruby C.Y. Lin, Ian W. Dawes, Andrew J. Brown, Peng Li, Xun Huang, Robert G. Parton, Markus R. Wenk, Tobias C. Walther, Hongyuan Yang	2011	300
5	miRNA Therapeutics: A New Class of Drugs with Potential Therapeutic Applications in the Heart Future Medicinal Chemistry ·Bianca C. Bernardo, Jenny Y. Y. Ooi, Ruby C.Y. Lin, Julie R. McMullen	2015	193
6	Reduced Phosphoinositide 3-Kinase (p110α) Activation Increases the Susceptibility to Atrial Fibrillation American Journal Of Pathology ·Lynette Pretorius, Xiao‐Jun Du, Elizabeth A. Woodcock, Helen Kiriazis, Ruby C.Y. Lin, Silvana Marasco, Robert L. Medcalf, Ziqiu Ming, Geoffrey A. Head, Joon Win Tan, Nelly Cemerlang, Junichi Sadoshima, Tetsuo Shioi, Seigo Izumo, Е. В. Лукошкова, Anthony M. Dart, Garry Jennings, Julie R. McMullen	2009	153
7	PI3K(p110α) Protects Against Myocardial Infarction-Induced Heart Failure Arteriosclerosis Thrombosis and Vascular Biology ·Ruby C.Y. Lin, Kate L. Weeks, Xiao‐Ming Gao, Rohan B. H. Williams, Bianca C. Bernardo, Helen Kiriazis, Vance B. Matthews, Elizabeth A. Woodcock, Russell D. Bouwman, Janelle P. Mollica, H. J. L. Speirs, Ian W. Dawes, Roger J. Daly, Tetsuo Shioi, Seigo Izumo, Mark A. Febbraio, Xiao‐Jun Du, Julie R. McMullen	2010	144
8	Paternal high‐fat diet consumption induces common changes in the transcriptomes of retroperitoneal adipose and pancreatic islet tissues in female rat offspring The FASEB Journal ·Sheau‐Fang Ng, Ruby C.Y. Lin, Chris Maloney, Neil A. Youngson, Julie A. Owens, Margaret J. Morris	2014	106
9	Plasma leptin is associated with insulin resistance independent of age, body mass index, fat mass, lipids, and pubertal development in nondiabetic adolescents International Journal of Obesity ·(unknown), Ruby C.Y. Lin, Nic Kormas, (unknown), (unknown), T. P. Gill, Ian D. Caterson	2004	101
10	Gene-expression profiling of peripheral blood mononuclear cells in sepsis* Critical Care Medicine ·Benjamin Tang, Anthony S. McLean, (unknown), (unknown), Ruby C.Y. Lin	2009	94
11	High penetrance, overweight, and glucocorticoid receptor variant: case-control study BMJ ·Ruby C.Y. Lin, William Y.S. Wang, Brian Morris	1999	93
12	The Use of Gene-Expression Profiling to Identify Candidate Genes in Human Sepsis American Journal of Respiratory and Critical Care Medicine ·Benjamin Tang, Anthony S. McLean, Ian W. Dawes, Stephen Huang, Ruby C.Y. Lin	2007	88
13	Gene-expression profiling of peripheral blood mononuclear cells in sepsis Critical Care Medicine ·Benjamin Tang, Anthony S. McLean, Stephen Huang, Ian W. Dawes, Ruby C.Y. Lin	2009	88
14	Association of Coronary Artery Disease With Glucocorticoid Receptor N363S Variant Hypertension ·Ruby C.Y. Lin, Xing Li Wang, Brian J. Morris	2003	86
15	Adipose-Specific Knockout of Seipin/Bscl2 Results in Progressive Lipodystrophy Diabetes ·Lu Liu, Qing‐qing Jiang, Xuhong Wang, Yuxi Zhang, Ruby C.Y. Lin, Sin Man Lam, Guanghou Shui, Linkang Zhou, Peng Li, Yuhui Wang, Xin Cui, Mingming Gao, Ling Zhang, Ying Lv, Guoheng Xu, Chaojie Liu, Dong Zhao, Hongyuan Yang	2014	85
16	Influence of atrial fibrillation on microRNA expression profiles in left and right atria from patients with valvular heart disease Physiological Genomics ·Nicola Cooley, Mark J. Cowley, Ruby C.Y. Lin, Silvana Marasco, (unknown), David M. Kaye, Anthony M. Dart, Elizabeth A. Woodcock	2011	77
17	A MicroRNA Guide for Clinicians and Basic Scientists: Background and Experimental Techniques Heart Lung and Circulation ·Bianca C. Bernardo, Fadi J. Charchar, Ruby C.Y. Lin, Julie R. McMullen	2011	75
18	Gene-expression profiling of Gram-positive and Gram-negative sepsis in critically ill patients* Critical Care Medicine ·Benjamin Tang, Anthony S. McLean, Ian W. Dawes, Stephen Huang, Mark J. Cowley, Ruby C.Y. Lin	2008	72
19	Association of Obesity, but not Diabetes or Hypertension, with Glucocorticoid Receptor N363S Variant Obesity Research ·Ruby C.Y. Lin, Xing Li Wang, Bronwen Dalziel, Ian D. Caterson, Brian J. Morris	2003	70
20	Silencing of miR-34a Attenuates Cardiac Dysfunction in a Setting of Moderate, but Not Severe, Hypertrophic Cardiomyopathy PLoS ONE ·Bianca C. Bernardo, Xiao‐Ming Gao, Yow Keat Tham, Helen Kiriazis, Catherine E. Winbanks, Jenny Y. Y. Ooi, Esther J. H. Boey, Susanna Obad, Sakari Kauppinen, Paul Gregorevic, Xiao‐Jun Du, Ruby C.Y. Lin, Julie R. McMullen	2014	67

About Ruby C.Y. Lin

Ruby C.Y. Lin is a scholar working on Molecular Biology, Cancer Research, Ecology, Physiology and Epidemiology, having authored 80 papers that have together received 4.9k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (14 papers), Bacteriophages and microbial interactions (13 papers), Adipose Tissue and Metabolism (9 papers), Circular RNAs in diseases (7 papers), Hormonal Regulation and Hypertension (6 papers), Estrogen and related hormone effects (4 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers) and Cardiac Fibrosis and Remodeling (4 papers). The work is most often cited by research in Cancer Research (754 citations), Biochemistry (280 citations), Aging (60 citations), Microbiology (199 citations) and Molecular Biology (2.1k citations). Ruby C.Y. Lin has collaborated with scholars based in Australia, United States and Switzerland. Frequent co-authors include Margaret J. Morris, Julie A. Owens, D. Ross Laybutt, Romain Barrès, Julie R. McMullen, Bianca C. Bernardo, Brian J. Morris, Ian W. Dawes, Jenny Y. Y. Ooi and Anthony S. McLean. Their work appears in journals such as The FASEB Journal, Journal of Thoracic Oncology, Hypertension, Critical Care Medicine and International Journal of Obesity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Ruby C.Y. Lin

Impact in

Papers in i

In The Last Decade

Ruby C.Y. Lin

Ruby C.Y. Lin's Hit Papers

Peers

Countries citing papers authored by Ruby C.Y. Lin

Fields of papers citing papers by Ruby C.Y. Lin

All Works

About Ruby C.Y. Lin

Explore authors with similar magnitude of impact

Papers in